Abdurrahman, A.; Rijal, M. A. S.; Yusuf, H.; Norhayati; Rizaldi, G. In Silico Study of Naringin As an Anti-HER-2 Receptor in the Treatment of Breast Cancer. Borneo J of Pharmascientech 2024, 8, 137-148.